ICU Medical ROE 2006-2018 | ICUI

Current and historical return on equity (ROE) values for ICU Medical (ICUI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. ICU Medical ROE for the three months ending September 30, 2018 was 15.20%.
ICU Medical ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.09B $1.26B 6.96%
2018-06-30 $0.09B $1.26B 7.13%
2018-03-31 $0.02B $1.23B 1.53%
2017-12-31 $0.07B $1.20B 6.00%
2017-09-30 $0.03B $1.14B 2.85%
2017-06-30 $0.05B $1.12B 5.38%
2017-03-31 $0.10B $1.14B 13.31%
2016-12-31 $0.06B $0.66B 10.16%
2016-09-30 $0.06B $0.65B 9.67%
2016-06-30 $0.06B $0.62B 9.50%
2016-03-31 $0.05B $0.60B 9.29%
2015-12-31 $0.05B $0.58B 8.17%
2015-09-30 $0.05B $0.57B 8.82%
2015-06-30 $0.04B $0.54B 7.20%
2015-03-31 $0.03B $0.52B 5.79%
2014-12-31 $0.03B $0.51B 5.31%
2014-09-30 $0.03B $0.49B 6.68%
2014-06-30 $0.04B $0.49B 7.97%
2014-03-31 $0.04B $0.47B 8.51%
2013-12-31 $0.04B $0.47B 9.32%
2013-09-30 $0.04B $0.43B 9.50%
2013-06-30 $0.04B $0.42B 10.11%
2013-03-31 $0.04B $0.40B 11.06%
2012-12-31 $0.04B $0.39B 11.26%
2012-09-30 $0.05B $0.37B 13.56%
2012-06-30 $0.04B $0.35B 13.33%
2012-03-31 $0.04B $0.34B 13.80%
2011-12-31 $0.04B $0.32B 14.38%
2011-09-30 $0.04B $0.31B 11.91%
2011-06-30 $0.04B $0.31B 12.39%
2011-03-31 $0.03B $0.29B 12.73%
2010-12-31 $0.03B $0.27B 11.72%
2010-09-30 $0.03B $0.26B 10.62%
2010-06-30 $0.02B $0.25B 9.30%
2010-03-31 $0.02B $0.25B 8.34%
2009-12-31 $0.03B $0.27B 9.34%
2009-09-30 $0.03B $0.28B 10.58%
2009-06-30 $0.03B $0.27B 11.74%
2009-03-31 $0.03B $0.26B 11.78%
2008-12-31 $0.03B $0.25B 10.59%
2008-09-30 $0.02B $0.24B 9.72%
2008-06-30 $0.02B $0.23B 8.58%
2008-03-31 $0.02B $0.22B 7.67%
2007-12-31 $0.02B $0.21B 10.74%
2007-09-30 $0.03B $0.22B 11.05%
2007-06-30 $0.03B $0.23B 11.53%
2007-03-31 $0.03B $0.23B 13.17%
2006-12-31 $0.03B $0.23B 11.74%
2006-09-30 $0.02B $0.22B 11.27%
2006-06-30 $0.02B $0.21B 11.87%
2006-03-31 $0.02B $0.20B 11.96%
2005-12-31 $0.02B $0.19B 11.43%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $5.190B $1.293B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.164B 26.13
Medtronic (MDT) Ireland $123.923B 18.53
Stryker (SYK) United States $69.625B 25.56
Boston Scientific (BSX) United States $55.366B 27.03
Baxter (BAX) United States $39.075B 24.08
Zimmer Biomet Holdings (ZBH) United States $25.222B 16.18
Smith & Nephew SNATS (SNN) United Kingdom $16.659B 0.00
ResMed (RMD) United States $14.394B 27.30
Canopy Growth (CGC) Canada $11.042B 0.00
Bio-Rad Laboratories (BIO) United States $8.100B 51.79
Aurora Cannabis (ACB) Canada $7.040B 50.36
Hill-Rom Holdings (HRC) United States $6.974B 21.57
Perrigo (PRGO) Ireland $6.650B 10.09
Insulet (PODD) United States $5.226B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.539B 0.00
Haemonetics (HAE) United States $4.489B 39.82
Agios Pharmaceuticals (AGIO) United States $3.462B 0.00
Hutchison China MediTech (HCM) China $3.417B 0.00
Neogen (NEOG) United States $3.281B 50.39
NuVasive (NUVA) United States $3.013B 28.03
National Vision Holdings (EYE) United States $2.624B 50.75
Quidel (QDEL) United States $2.574B 23.28
Aphria (APHA) $2.402B 106.67
NxStage Medical (NXTM) United States $1.954B 0.00
AtriCure (ATRC) United States $1.279B 0.00
Phibro Animal Health (PAHC) United States $1.231B 17.70
VAREX IMAGING (VREX) United States $1.198B 23.45
Cardiovascular Systems (CSII) United States $1.170B 840.00
MacroGenics (MGNX) United States $0.923B 0.00
Cerus (CERS) United States $0.878B 0.00
PetIQ (PETQ) United States $0.837B 21.68
Surmodics (SRDX) United States $0.766B 111.39
Evolus (EOLS) United States $0.747B 0.00
NanoString Technologies (NSTG) United States $0.719B 0.00
Lantheus Holdings (LNTH) United States $0.713B 22.07
Meridian Bioscience (VIVO) United States $0.704B 20.98
OraSure Technologies (OSUR) United States $0.703B 31.03
Omeros (OMER) United States $0.688B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.625B 20.05
Quanterix (QTRX) United States $0.505B 0.00
LeMaitre Vascular (LMAT) United States $0.492B 24.18
Owens & Minor (OMI) United States $0.479B 5.42
TG Therapeutics (TGTX) United States $0.395B 0.00
Insys Therapeutics (INSY) United States $0.368B 0.00
Utah Medical Products (UTMD) United States $0.334B 21.65
BioLife Solutions (BLFS) United States $0.299B 404.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.293B 0.00
Bovie Medical (APYX) United States $0.279B 0.00
Vapotherm (VAPO) United States $0.276B 0.00
Cytosorbents (CTSO) United States $0.262B 0.00
Rockwell Medical (RMTI) United States $0.242B 0.00
Zynex (ZYXI) United States $0.165B 15.97
Surface Oncology (SURF) United States $0.150B 0.00
Fonar (FONR) United States $0.143B 7.65
Chembio Diagnostics (CEMI) United States $0.119B 0.00
Chimerix (CMRX) United States $0.101B 0.00
United-Guardian (UG) United States $0.091B 18.98
Female Health (VERU) United States $0.084B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.33
Conatus Pharmaceuticals (CNAT) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 13.57